Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma. | Transl Gastroenterol Hepatol | 2023 | 38021355 | PubTator, text mining | PubMed |
| Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization study. | BMC Med | 2023 | 38017422 | PubTator, text mining | PubMed |
| Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3I148M risk allele. | Hepatol Commun | 2023 | 38015590 | PubTator, text mining | PubMed |
| Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review. | Life (Basel) | 2023 | 38004284 | PubTator, text mining | PubMed |
| Insulin Resistance: A Marker for Fat-to-Lean Body Composition in Japanese Adults. | Nutrients | 2023 | 38004118 | PubTator, text mining | PubMed |
| Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study. | Medicina (Kaunas) | 2023 | 38003983 | PubTator, text mining | PubMed |
| Identification of 13 Novel Loci in a Genome-Wide Association Study on Taiwanese with Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 38003606 | PubTator, text mining | PubMed |
| Mitochondrial GpC and CpG DNA Hypermethylation Cause Metabolic Stress-Induced Mitophagy and Cholestophagy. | Int J Mol Sci | 2023 | 38003603 | PubTator, text mining | PubMed |
| From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention. | Cancers (Basel) | 2023 | 38001718 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication. | Metabolites | 2023 | 37999215 | PubTator, text mining | PubMed |
| Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease. | Metabolites | 2023 | 37999211 | PubTator, text mining | PubMed |
| Molecular Aspects of MAFLD-New Insights on Pathogenesis and Treatment. | Curr Issues Mol Biol | 2023 | 37998750 | PubTator, text mining | PubMed |
| Transcriptomic profiles reveal the characteristics of oocytes and cumulus cells at GV, MI, and MII in follicles before ovulation. | J Ovarian Res | 2023 | 37993893 | PubTator, text mining | PubMed |
| Modeling Liver Development and Disease in a Dish. | Int J Mol Sci | 2023 | 37958904 | PubTator, text mining | PubMed |
| Exploring the association between circRNA expression and pediatric obesity based on a case-control study and related bioinformatics analysis. | BMC Pediatr | 2023 | 37957626 | PubTator, text mining | PubMed |
| Mechanisms of liver fibrosis in metabolic syndrome. | eGastroenterology | 2023 | 37946713 | PubTator, text mining | PubMed |
| Parental metabolic syndrome and elevated liver transaminases are risk factors for offspring, even in children and adolescents with a normal body mass index. | Front Nutr | 2023 | 37941769 | PubTator, text mining | PubMed |
| The Impact and Burden of Dietary Sugars on the Liver. | Hepatol Commun | 2023 | 37930128 | PubTator, text mining | PubMed |
| Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease. | Lipids Health Dis | 2023 | 37924128 | PubTator, text mining | PubMed |
| TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease. | Hepatol Forum | 2023 | 37920782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=27